Humacyte Inc (HUMA)
$0.41 -12.47% Close Oct 30, 2026 Live
Humacyte stock today
Humacyte closed at $0.41 on October 30, 2026, down 12.47% on the day. Over the past year it returned -74.6% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $91.0 million.
$0.50$1.00$1.50
NovJan 2026MarMayJulSep
| Period | HUMA | S&P 500 (SPY) |
|---|---|---|
| 1 month | -20.6% | -0.9% |
| 3 months | -38.8% | +2.1% |
| Year to date | -57.2% | +11.7% |
| 1 year | -74.6% | +12.4% |
| 3 years | -79.8% | +88.5% |
| 5 years | -95.5% | +76.0% |
Key statistics
- Market value
- $91.0M
- Price / sales
- 42.9
- 52-week range
- $0.35 to $1.67
- Next report
- Nov 12, 2026 (estimated)
About Humacyte
Develops and manufactures bioengineered human tissue products for medical applications.
Sector: Health Care
More on Humacyte
- Financials: revenue, earnings and segmentsRevenue +30% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $45.19 today
No forecast, no recommendation. This page describes Humacyte Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.